Skip to main content

Advertisement

SpringerLink
Log in

Clinical Utility of Celiac Disease-Associated HLA Testing

  • Original Article
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Background

Negative predictive value (NPV) of celiac disease (CD)-related human leukocyte antigens (HLA) DQ2 and DQ8 approaches 100 % in individual patients. However, studies evaluating its exclusionary utility in patient groups are lacking.

Aim

We aim to assess the performance of HLA testing when applied to patient groups with varying characteristics and propose evidence-based recommendations for its clinical use.

Methods

Demographic and clinical information was recorded in patients undergoing HLA testing. Using predetermined criteria, patients were classified as CD, non-CD, or indeterminate. Diagnostic yield of HLA testing was defined as the percentage of patients in whom CD could be excluded based on negative HLA test.

Results

Two hundred and fifty-six patients underwent testing for CD-related HLA DQ2 and DQ8. 102 (100 non-CD, 2 CD) patients tested HLA negative for a 98 % NPV and 39 % diagnostic yield. Diagnostic yield was highest (60 %) in patients with intraepithelial lymphocytosis plus normal IgA tissue transglutaminase antibody (IgA-tTG) and lowest in patients with positive IgA-tTG plus villous atrophy (0 %). CD was diagnosed in two HLA-negative patients, who carried half of DQ2.5 trans genotype.

Conclusions

Diagnostic yield of CD-related HLA testing varies widely depending on clinical indication. HLA testing is a practical and valuable test for most patients in whom initial evaluation for CD is inconclusive. A negative HLA result usually obviates the need for further celiac testing including endoscopy and gluten challenge. Rarely, in patients reported as HLA negative, half of HLA DQ2.5 (cis or trans) is sufficient for development of CD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Cook HB, Burt MJ, Collett JA, et al. Adult coeliac disease: prevalence and clinical significance. J Gastroenterol Hepatol. 2000;15:1032–1036.

    Article  CAS  PubMed  Google Scholar 

  2. Maki M, Mustalahti K, Kokkonen J, et al. Prevalence of celiac disease among children in Finland. N Engl J Med. 2003;348:2517–2524.

    Article  PubMed  Google Scholar 

  3. Sanders DS, Patel D, Stephenson TJ, et al. A primary care cross-sectional study of undiagnosed adult coeliac disease. Eur J Gastroenterol Hepatol. 2003;15:407–413.

    Article  CAS  PubMed  Google Scholar 

  4. Accomando S, Cataldo F. The global village of celiac disease. Dig Liver Dis. 2004;36:492–498.

    Article  CAS  PubMed  Google Scholar 

  5. Fasano A, Berti I, Gerarduzzi T, et al. Prevalence of celiac disease in at-risk and not-at-risk groups in the United States: a large multicenter study. Arch Intern Med. 2003;163:286–292.

    Article  PubMed  Google Scholar 

  6. Rensch MJ, Merenich JA, Lieberman M, et al. Gluten-sensitive enteropathy in patients with insulin-dependent diabetes mellitus. Ann Intern Med. 1996;124:564–567.

    Article  CAS  PubMed  Google Scholar 

  7. Cronin CC, Feighery A, Ferriss JB, et al. High prevalence of celiac disease among patients with insulin-dependent (type I) diabetes mellitus. Am J Gastroenterol. 1997;92:2210–2212.

    CAS  PubMed  Google Scholar 

  8. Mainardi E, Montanelli A, Dotti M, et al. Thyroid-related autoantibodies and celiac disease: a role for a gluten-free diet? J Clin Gastroenterol. 2002;35:245–248.

    Article  CAS  PubMed  Google Scholar 

  9. Berti I, Trevisiol C, Tommasini A, et al. Usefulness of screening program for celiac disease in autoimmune thyroiditis. Dig Dis Sci. 2000;45:403–406.

    Article  CAS  PubMed  Google Scholar 

  10. Ch’ng CL, Biswas M, Benton A, et al. Prospective screening for coeliac disease in patients with Graves’ hyperthyroidism using anti-gliadin and tissue transglutaminase antibodies. Clin Endocrinol (Oxf). 2005;62:303–306.

    Article  Google Scholar 

  11. Corazza G, Valentini RA, Frisoni M, et al. Gliadin immune reactivity is associated with overt and latent enteropathy in relatives of celiac patients. Gastroenterology. 1992;103:1517–1522.

    CAS  PubMed  Google Scholar 

  12. Farre C, Humbert P, Vilar P, et al. Serological markers and HLA-DQ2 haplotype among first-degree relatives of celiac patients. Catalonian Coeliac Disease Study Group. Dig Dis Sci. 1999;44:2344–2349.

    Article  CAS  PubMed  Google Scholar 

  13. Book L, Zone JJ, Neuhausen SL. Prevalence of celiac disease among relatives of sib pairs with celiac disease in U.S. families. Am J Gastroenterol. 2003;98:377–381.

    Article  PubMed  Google Scholar 

  14. Lohi S, Mustalahti K, Kaukinen K, et al. Increasing prevalence of coeliac disease over time. Aliment Pharmacol Ther. 2007;26:1217–1225.

    Article  CAS  PubMed  Google Scholar 

  15. Rubio-Tapia A, Kyle RA, Kaplan EL, et al. Increased prevalence and mortality in undiagnosed celiac disease. Gastroenterology. 2009;137:88–93.

    Article  PubMed Central  PubMed  Google Scholar 

  16. Collin P, Kaukinen K, Vogelsang H, et al. Antiendomysial and antihuman recombinant tissue transglutaminase antibodies in the diagnosis of coeliac disease: a biopsy-proven European multicentre study. Eur J Gastroenterol Hepatol. 2005;17:85–91.

    Article  CAS  PubMed  Google Scholar 

  17. Leffler DA, Schuppan D. Update on serologic testing in celiac disease. Am J Gastroenterol. 2010;105:2520–2524.

    Article  PubMed  Google Scholar 

  18. Lewis NR, Scott BB. Systematic review: the use of serology to exclude or diagnose coeliac disease (a comparison of the endomysial and tissue transglutaminase antibody tests). Aliment Pharmacol Ther. 2006;24:47–54.

    Article  CAS  PubMed  Google Scholar 

  19. Hill ID. What are the sensitivity and specificity of serologic tests for celiac disease? Do sensitivity and specificity vary in different populations? Gastroenterology. 2005;128:S25–S32.

    Article  PubMed  Google Scholar 

  20. Ludvigsson JF, Leffler DA, Bai JC, et al. The Oslo definitions for coeliac disease and related terms. Gut. 2013;62(1):43–52.

    Article  PubMed Central  PubMed  Google Scholar 

  21. Volta U, Fabbri A, Parisi C, et al. Old and new serological tests for celiac disease screening. Expert Rev Gastroenterol Hepatol. 2010;4:31–35.

    Article  CAS  PubMed  Google Scholar 

  22. Salmi TT, Collin P, Korponay-Szabo IR, et al. Endomysial antibody-negative coeliac disease: clinical characteristics and intestinal autoantibody deposits. Gut. 2006;55:1746–1753.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  23. Rostom A, Murray JA, Kagnoff MF. American Gastroenterological Association (AGA) Institute technical review on the diagnosis and management of celiac disease. Gastroenterology. 2006;131:1981–2002.

    Article  PubMed  Google Scholar 

  24. Pellegrino S, Villanacci V, Sansotta N, et al. Redefining the intraepithelial lymphocytes threshold to diagnose gluten sensitivity in patients with architecturally normal duodenal histology. Aliment Pharmacol Ther. 2011;33:697–706.

    Article  CAS  PubMed  Google Scholar 

  25. Biagi F, Bianchi PI, Campanella J, et al. The prevalence and the causes of minimal intestinal lesions in patients complaining of symptoms suggestive of enteropathy: a follow-up study. J Clin Pathol. 2008;61:1116–1118.

    Article  CAS  PubMed  Google Scholar 

  26. Chang F, Mahadeva U, Deere H. Pathological and clinical significance of increased intraepithelial lymphocytes (IELs) in small bowel mucosa. APMIS. 2005;113:385–399.

    Article  PubMed  Google Scholar 

  27. Ravelli A, Villanacci V, Monfredini C, et al. How patchy is patchy villous atrophy?: distribution pattern of histological lesions in the duodenum of children with celiac disease. Am J Gastroenterol. 2010;105:2103–2110.

    Article  PubMed  Google Scholar 

  28. Pallav K, Leffler DA, Tariq S, et al. Noncoeliac enteropathy: the differential diagnosis of villous atrophy in contemporary clinical practice. Aliment Pharmacol Ther. 2012;35:380–390.

    Article  CAS  PubMed  Google Scholar 

  29. Leffler D, Schuppan D, Pallav K, et al. Kinetics of the histological, serological and symptomatic responses to gluten challenge in adults with coeliac disease. Gut. 2013;62:996–1004.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  30. Lundin KE, Gjertsen HA, Scott H, et al. Function of DQ2 and DQ8 as HLA susceptibility molecules in celiac disease. Hum Immunol. 1994;41:24–27.

    Article  CAS  PubMed  Google Scholar 

  31. Sollid LM. Molecular basis of celiac disease. Annu Rev Immunol. 2000;18:53–81.

    Article  CAS  PubMed  Google Scholar 

  32. Schuppan D. Current concepts of celiac disease pathogenesis. Gastroenterology. 2000;119:234–242.

    Article  CAS  PubMed  Google Scholar 

  33. Kagnoff MF. Overview and pathogenesis of celiac disease. Gastroenterology. 2005;128:S10–S18.

    Article  CAS  PubMed  Google Scholar 

  34. Hadithi M, von Blomberg BM, Crusius JB, et al. Accuracy of serologic tests and HLA-DQ typing for diagnosing celiac disease. Ann Intern Med. 2007;147:294–302.

    Article  PubMed  Google Scholar 

  35. Green PH, Jabri B. Celiac disease. Annu Rev Med. 2006;57:207–221.

    Article  CAS  PubMed  Google Scholar 

  36. Sollid LM, Markussen G, Ek J, et al. Evidence for a primary association of celiac disease to a particular HLA-DQ alpha/beta heterodimer. J Exp Med. 1989;169:345–350.

    Article  CAS  PubMed  Google Scholar 

  37. Spurkland A, Sollid LM, Polanco I, et al. HLA-DR and -DQ genotypes of celiac disease patients serologically typed to be non-DR3 or non-DR5/7. Hum Immunol. 1992;35:188–192.

    Article  CAS  PubMed  Google Scholar 

  38. Wolters VM, Wijmenga C. Genetic background of celiac disease and its clinical implications. Am J Gastroenterol. 2008;103:190–195.

    Article  PubMed  Google Scholar 

  39. Sollid LM, Lie BA. Celiac disease genetics: current concepts and practical applications. Clin Gastroenterol Hepatol. 2005;3:843–851.

    Article  CAS  PubMed  Google Scholar 

  40. Petronzelli F, Bonamico M, Ferrante P, et al. Genetic contribution of the HLA region to the familial clustering of coeliac disease. Ann Hum Genet. 1997;61:307–317.

    Article  CAS  PubMed  Google Scholar 

  41. Megiorni F, Mora B, Bonamico M, et al. HLA-DQ and risk gradient for celiac disease. Hum Immunol. 2009;70:55–59.

    Article  CAS  PubMed  Google Scholar 

  42. Pietzak MM, Schofield TC, McGinniss MJ, et al. Stratifying risk for celiac disease in a large at-risk United States population by using HLA alleles. Clin Gastroenterol Hepatol. 2009;7:966–971.

    Article  PubMed  Google Scholar 

  43. Murray JA, Moore SB, Van Dyke CT, et al. HLA DQ gene dosage and risk and severity of celiac disease. Clin Gastroenterol Hepatol. 2007;5:1406–1412.

    Article  PubMed Central  PubMed  Google Scholar 

  44. Biagi F, Bianchi PI, Vattiato C, et al. Influence of HLA-DQ2 and DQ8 on severity in celiac disease. J Clin Gastroenterol. 2012;46:46–50.

    Article  PubMed  Google Scholar 

  45. Megiorni F, Mora B, Bonamico M, et al. HLA-DQ and susceptibility to celiac disease: evidence for gender differences and parent-of-origin effects. Am J Gastroenterol. 2008;103:997–1003.

    Article  PubMed  Google Scholar 

  46. Chang M, Green PH. Genetic testing before serologic screening in relatives of patients with celiac disease as a cost containment method. J Clin Gastroenterol. 2009;43:43–50.

    Article  PubMed  Google Scholar 

  47. Liu E, Rewers M, Eisenbarth GS. Genetic testing: who should do the testing and what is the role of genetic testing in the setting of celiac disease? Gastroenterology. 2005;128:S33–S37.

    Article  PubMed  Google Scholar 

  48. Clouzeau-Girard H, Rebouissoux L, Taupin JL, et al. HLA-DQ genotyping combined with serological markers for the diagnosis of celiac disease: is intestinal biopsy still mandatory? J Pediatr Gastroenterol Nutr. 2011;52:729–733.

    Article  CAS  PubMed  Google Scholar 

  49. Karinen H, Karkkainen P, Pihlajamaki J, et al. HLA genotyping is useful in the evaluation of the risk for coeliac disease in the 1st-degree relatives of patients with coeliac disease. Scand J Gastroenterol. 2006;41:1299–1304.

    Article  CAS  PubMed  Google Scholar 

  50. Karell K, Louka AS, Moodie SJ, et al. HLA types in celiac disease patients not carrying the DQA1*05-DQB1*02 (DQ2) heterodimer: results from the European Genetics Cluster on Celiac Disease. Hum Immunol. 2003;64:469–477.

    Article  CAS  PubMed  Google Scholar 

  51. Mubarak A, Spierings E, Wolters V, et al. Human leukocyte antigen DQ2.2 and celiac disease. J Pediatr Gastroenterol Nutr. 2013;56:428–430.

    Article  CAS  PubMed  Google Scholar 

  52. Romanos J, van Diemen CC, Nolte IM, et al. Analysis of HLA and non-HLA alleles can identify individuals at high risk for celiac disease. Gastroenterology. 2009;137:834–840. 840e831–840e833.

    Article  CAS  PubMed  Google Scholar 

  53. Dubois PC, Trynka G, Franke L, et al. Multiple common variants for celiac disease influencing immune gene expression. Nat Genet. 2010;42:295–302.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  54. Kapitany A, Toth L, Tumpek J, et al. Diagnostic significance of HLA-DQ typing in patients with previous coeliac disease diagnosis based on histology alone. Aliment Pharmacol Ther. 2006;24:1395–1402.

    Article  CAS  PubMed  Google Scholar 

  55. Cooper BT, Holmes GK, Ferguson R, et al. Gluten-sensitive diarrhea without evidence of celiac disease. Gastroenterology. 1980;79:801–806.

    CAS  PubMed  Google Scholar 

  56. Biesiekierski JR, Newnham ED, Irving PM, et al. Gluten causes gastrointestinal symptoms in subjects without celiac disease: a double-blind randomized placebo-controlled trial. Am J Gastroenterol. 2011;106:508–514. (quiz 515).

    Article  CAS  PubMed  Google Scholar 

  57. Di Sabatino A, Corazza GR. Nonceliac gluten sensitivity: sense or sensibility? Ann Intern Med. 2012;156:309–311.

    Article  PubMed  Google Scholar 

  58. Madsen C. Prevalence of food allergy: an overview. Proc Nutr Soc. 2005;64:413–417.

    Article  PubMed  Google Scholar 

  59. Kaukinen K, Partanen J, Maki M, et al. HLA-DQ typing in the diagnosis of celiac disease. Am J Gastroenterol. 2002;97:695–699.

    Article  PubMed  Google Scholar 

  60. Leffler DA, Dennis M, Hyett B, et al. Etiologies and predictors of diagnosis in nonresponsive celiac disease. Clin Gastroenterol Hepatol. 2007;5:445–450.

    Article  PubMed  Google Scholar 

  61. Troncone R. Latent coeliac disease in Italy. The SIGEP Working Group on Latent Coeliac Disease. Italian Society for Paediatric Gastroenterology and Hepatology. Acta Paediatr. 1995;84:1252–1257.

    Article  CAS  PubMed  Google Scholar 

  62. Collin P, Helin H, Maki M, et al. Follow-up of patients positive in reticulin and gliadin antibody tests with normal small-bowel biopsy findings. Scand J Gastroenterol. 1993;28:595–598.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgment

This study was supported by unrestricted research grant from Prometheus Laboratories.

Conflict of interest

Daniel Leffler has served research support and/or consulted for Prometheus Laboratories, Shire Pharmaceuticals, Alvine Pharmaceuticals, Alba Therapeutics, Ironwood Pharmaceuticals, and Inova Diagnostics. Ciaran P. Kelly has acted as scientific advisor for Alvine Pharmaceuticals, Alba Therapeutics, and ImmunosanT.

Author information

Authors and Affiliations

  1. The Celiac Center, Beth Israel Deaconess Medical Center, Harvard Medical School, 330 Brookline Avenue, Boston, MA, 02215, USA

    Kumar Pallav, Toufic Kabbani, Sohaib Tariq, Rohini Vanga, Ciaran P. Kelly & Daniel A. Leffler

Authors
  1. Kumar Pallav
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Toufic Kabbani
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sohaib Tariq
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Rohini Vanga
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Ciaran P. Kelly
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Daniel A. Leffler
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Daniel A. Leffler.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pallav, K., Kabbani, T., Tariq, S. et al. Clinical Utility of Celiac Disease-Associated HLA Testing. Dig Dis Sci 59, 2199–2206 (2014). https://doi.org/10.1007/s10620-014-3143-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-014-3143-1

Keywords

Search

Navigation